David P. Southwell - Dec 23, 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Signature
/s/ David P. Southwell
Stock symbol
TCRX
Transactions as of
Dec 23, 2021
Transactions value $
$95,880
Form type
4
Date filed
12/27/2021, 03:30 PM
Previous filing
Sep 9, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRX Voting Common Stock Options Exercise $95.9K +48.7K +49.71% $1.97 147K Dec 23, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Options Exercise $0 -48.7K -69.7% $0.00 21.2K Dec 23, 2021 Voting Common Stock 48.7K $1.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares originally subject to this option vested over 4 years of service following October 9, 2018, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. In addition, all of the shares subject to this option shall vest and become fully exercisable upon a Change of Control (as defined in the option agreement).